Argos Therapeutics, Inc. 4233 Technology Drive Durham, Nc 27704 (August 15th, 2016)
This letter agreement (the "Agreement") shall serve to amend and restate the terms and conditions of the employment offer letter dated February 3, 2015 (the "Offer Letter") between you and Argos Therapeutics, Inc. ("Argos Therapeutics" or the "Company") in its entirety, and shall become effective as of May 16, 2016 (the "Effective Date").
Argos Therapeutics, Inc. 4233 Technology Drive Durham, Nc 27704 (July 11th, 2016)
Argos Therapeutics, Inc. 4233 Technology Drive Durham, Nc 27704 (May 16th, 2016)
Confidential Separation Agreement and General Release (January 8th, 2014)
This Confidential Separation Agreement and General Release (the Agreement) is made and entered into by and between David J. Lockhart, residing at 155 South Nardo Avenue, Solana Beach, CA 92075 (Employee), and Amicus Therapeutics, Inc., on its own behalf and, as applicable, on behalf of its present and former directors, officers, partners, employees, representatives, agents, contractors, attorneys, parent companies, subsidiaries, affiliates, successors, heirs, predecessors, and assigns (Amicus, Company, or Employer), (collectively the Parties).
April 18, 2013 Joan Winterbottom Senior Vice President, Human Resources Amicus Therapeutics, Inc. Dear Joan: (August 7th, 2013)
Reference is hereby made to that certain letter agreement by and between you and Amicus Therapeutics, Inc. (the Company) dated July 26, 2012 (the Letter Agreement).